GLP-2 medications are a different type of medication
Lipidomics, metabolomics and proteomics analysis At baseline, the two treatment groups exhibited distinct lipidomic and metabolomic profiles, with differences in glycerophosphocholine, monoacylglycerol (MAG), and triradylglycerols in lipidomics (Supplementary Fig
Shoaei-Hagh P, Kamelan Kafi F, Najafi S, Zamanzadeh M, Heidari Bakavoli A, Ramezani J, et al
This includes getting consistent sleep, eating enough protein, staying hydrated, strength training, avoiding overtraining, limiting alcohol, managing stress, following your dosing schedule, keeping follow-up appointments, and tracking symptoms or measurements
Additional datasets analyzed during the current study are available from the corresponding author upon reasonable request
A meaningful percentage of people starting semaglutide or tirzepatide discontinue due to side effects